The convergence of cloud, data and AI is revolutionizing the pharmaceutical industry, creating a powerful ecosystem that drives innovation at scale across the entire value chain. At Gilead, teams harness these technologies on a unified cloud, data, & AI platform, accelerating business processes in pre-clinical and clinical stage, enabling smarter manufacturing and commercial processes, and deliver AI initiatives by reusing data products. Gilead will discuss how they have leveraged AWS, Databricks, and Data Mesh to manage vast amounts of heterogeneous data. Also, showcase use cases of traditional AI/ML, and Generative AI, and a Marketplace approach to drive adoption of AI Agents, demonstrating how this cloud-based, AI-powered platform is transforming the entire value chain. Gilead will also discuss how they are exploring the future of pharmaceutical innovation through Agentic AI, where the synergy of cloud, data and AI is unlocking new possibilities for a healthier world. In the second part, Muddu Sudhakar, Founder and Investor, will discuss how organizations can build and buy solutions for AI, Agents with Data Platforms. AWS and Databricks provide industry-leading platforms to build Agentic AI solutions. We will also cover Agentic AI Platform, Agent orchestration, Agent Interoperability, Agent Guardrails and Agentic workflows. This discussion also covers challenges in deploying and managing Agentic AI platforms. Enterprises need impactful AI initiatives & Agents to realize the promise and vision of AI and drive significant ROI.